EP3283648A4 - Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques - Google Patents

Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques Download PDF

Info

Publication number
EP3283648A4
EP3283648A4 EP16780637.1A EP16780637A EP3283648A4 EP 3283648 A4 EP3283648 A4 EP 3283648A4 EP 16780637 A EP16780637 A EP 16780637A EP 3283648 A4 EP3283648 A4 EP 3283648A4
Authority
EP
European Patent Office
Prior art keywords
microbiome
therapeutics
health issues
neurological health
derived diagnostics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780637.1A
Other languages
German (de)
English (en)
Other versions
EP3283648A1 (fr
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283648A1 publication Critical patent/EP3283648A1/fr
Publication of EP3283648A4 publication Critical patent/EP3283648A4/fr
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/002Electrode membranes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/301Anxiety or phobic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/304Mood disorders, e.g. bipolar, depression
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/30Psychoses; Psychiatry
    • G01N2800/305Attention deficit disorder; Hyperactivity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Databases & Information Systems (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP16780637.1A 2015-04-13 2016-04-13 Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques Pending EP3283648A4 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201562146852P 2015-04-13 2015-04-13
US201562146810P 2015-04-13 2015-04-13
US201562146833P 2015-04-13 2015-04-13
US201562147315P 2015-04-14 2015-04-14
US201562147058P 2015-04-14 2015-04-14
US201562147124P 2015-04-14 2015-04-14
US201562147077P 2015-04-14 2015-04-14
US201562147337P 2015-04-14 2015-04-14
PCT/US2016/027312 WO2016168316A1 (fr) 2015-04-13 2016-04-13 Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques

Publications (2)

Publication Number Publication Date
EP3283648A1 EP3283648A1 (fr) 2018-02-21
EP3283648A4 true EP3283648A4 (fr) 2019-03-20

Family

ID=57126241

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780637.1A Pending EP3283648A4 (fr) 2015-04-13 2016-04-13 Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques

Country Status (4)

Country Link
EP (1) EP3283648A4 (fr)
CN (1) CN107709576B (fr)
AU (1) AU2016248050A1 (fr)
WO (1) WO2016168316A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018094376A1 (fr) * 2016-11-21 2018-05-24 uBiome, Inc. Procédé et système pour caractériser une affection liée à une céphalée
KR101944660B1 (ko) * 2018-01-29 2019-01-31 주식회사 엠디헬스케어 세균 메타게놈 분석을 통한 우울증 진단방법
CN109785915B (zh) * 2018-12-24 2021-03-19 东软集团股份有限公司 数据征集方法,装置,存储介质及电子设备
CN109697718A (zh) * 2018-12-25 2019-04-30 电子科技大学 一种基于图论的自闭症检测方法及装置
EP3952745A1 (fr) * 2019-04-10 2022-02-16 Genting Taurx Diagnostic Centre SDN BHD Procédé de test adaptatif neurologique
CN111429977B (zh) * 2019-09-05 2024-02-13 中国海洋大学 一种新的基于图结构注意力的分子相似性搜索算法
CN111370116A (zh) * 2020-03-18 2020-07-03 浙江大学 双相情感障碍疗效预测的肠道微生物标志物及其筛选应用
CN114334003B (zh) * 2021-12-22 2023-03-17 中国水产科学研究院南海水产研究所 基于单分子测序的发酵金鲳深度学习质量判别方法及系统
CN115998773A (zh) * 2022-09-19 2023-04-25 重庆医科大学 假长双歧杆菌在制备治疗注意缺陷多动障碍的药物中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120252775A1 (en) * 2010-05-26 2012-10-04 Sydney Martin Finegold Method for diagnosing, preventing, and treating neurological diseases
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (fr) * 2013-07-21 2015-01-29 Whole Biome, Inc. Procédés et systèmes de caractérisation, de surveillance et de traitement du microbiome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110177976A1 (en) * 2008-06-30 2011-07-21 The Washington University Methods for promoting weight loss and associated arrays
CA2807242C (fr) * 2010-08-04 2017-05-02 Thomas Julius Borody Compositions pour une transplantation florale de matieres fecales et leurs procedes de fabrication et d'utilisation et dispositifs pour leur administration
WO2013008102A2 (fr) * 2011-07-14 2013-01-17 R.E.D. Laboratories N.V../ S.A. Procédés et compositions pour évaluer et/ou traiter des maladies immunitaires chroniques
WO2014036182A2 (fr) * 2012-08-29 2014-03-06 California Institute Of Technology Diagnostic et traitement du trouble du spectre autistique
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120252775A1 (en) * 2010-05-26 2012-10-04 Sydney Martin Finegold Method for diagnosing, preventing, and treating neurological diseases
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (fr) * 2013-07-21 2015-01-29 Whole Biome, Inc. Procédés et systèmes de caractérisation, de surveillance et de traitement du microbiome

Also Published As

Publication number Publication date
AU2016248050A1 (en) 2017-11-09
CN107709576A (zh) 2018-02-16
EP3283648A1 (fr) 2018-02-21
CN107709576B (zh) 2022-06-03
WO2016168316A1 (fr) 2016-10-20

Similar Documents

Publication Publication Date Title
EP3347496A4 (fr) Méthode et système de diagnostics dérivés du microbiome et traitements thérapeutiques pour la santé bucco-dentaire
EP3347495A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé gastro-intestinale
EP3209803A4 (fr) Procédé et système de diagnostic et de thérapie fondés sur le microbiome
EP3397150A4 (fr) Système et procédés de surveillance neurologique et de diagnostic assisté
EP3218074A4 (fr) Système et procédé destinés à offrir une expérience d'un tour en réalité alternée
EP3221340C0 (fr) Procédé de diagnostic employant de la lipocaline neutrophile humaine (hnl)
EP3283648A4 (fr) Méthode et système de diagnostic dérivé du microbiome et de traitement de problèmes thérapeutiques destinés à des problèmes de santé neurologiques
EP3223263A4 (fr) Simulateur de cathéter et procédé d'imagerie pour un simulateur de cathéter
EP3161465A4 (fr) Système et procédé de détection de qualité d'huile
EP3347367A4 (fr) Procédé et système de diagnostic et de thérapie dérivés du microbiome pour la vaginose bactérienne
EP3346912A4 (fr) Procédé et système pour des diagnostics dérivés du microbiome et agents thérapeutiques pour des affections associées à la santé cérébro-carniofaciale
EP3283086A4 (fr) Procédé et système de diagnostic et de traitement dérivés du microbiome pour des pathologies associées aux caractéristiques fonctionnelles du microbiome
EP3346910A4 (fr) Procédé et système pour diagnostics dérivés du microbiome et agents thérapeutiques contre l'eczéma
SG11201700739QA (en) System and method for modular ride vehicles
EP3117231A4 (fr) Système et procédé d'imagerie multicanal à champ faible
EP3299918A4 (fr) Système de diagnostic d'anomalies et procédé de diagnostic d'anomalies
EP3229093A4 (fr) Procédé de diagnostic d'anomalie et système de diagnostic d'anomalie
EP3096605A4 (fr) Absorbant granulaire trempé et système et procédé de fabrication d'absorbant granulaire trempé
EP3105965A4 (fr) Système et procédé de ré-hébergement de connexion
EP3283084A4 (fr) Procédé et système de caractérisation, de diagnostics et de traitements dérivés du microbiome pour des dermatoses
EP3111700A4 (fr) Système et procédé de transfert spécifique à un ue
EP3340804A4 (fr) Système et procédé de détection de qualité d'huile
EP3120162A4 (fr) Système et procédé pour effectuer un diagnostic de transformateur
EP3335380A4 (fr) Procédé et système de diagnostic de transaction
EP3355778A4 (fr) Système et procédé pour optimiser les interactions corps-objet

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/74 20150101ALI20181109BHEP

Ipc: C12Q 1/68 20180101ALI20181109BHEP

Ipc: C12Q 1/689 20180101ALI20181109BHEP

Ipc: C12Q 1/6883 20180101ALI20181109BHEP

Ipc: G06F 19/24 20110101ALI20181109BHEP

Ipc: G06F 19/18 20110101AFI20181109BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190218

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/74 20150101ALI20190306BHEP

Ipc: C12Q 1/68 20180101AFI20190306BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190918

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231107